These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. Chen P, Cameron R, Wang J, Vallis KA, Reilly RM. J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194 [Abstract] [Full Text] [Related]
13. Design, characterization and in vitro evaluation of SMEDDS containing an anticancer peptide, linear LyP-1. Gürsoy RN, Çevik Ö. Pharm Dev Technol; 2014 Jun; 19(4):486-90. PubMed ID: 23678858 [Abstract] [Full Text] [Related]
14. 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice. McLarty K, Fasih A, Scollard DA, Done SJ, Vines DC, Green DE, Costantini DL, Reilly RM. J Nucl Med; 2009 Nov; 50(11):1848-56. PubMed ID: 19837760 [Abstract] [Full Text] [Related]
18. 99mTc-Labeled LyP-1 for SPECT Imaging of Triple Negative Breast Cancer. Song N, Zhao L, Zhu M, Zhao J. Contrast Media Mol Imaging; 2019 Nov; 2019():9502712. PubMed ID: 31598115 [Abstract] [Full Text] [Related]